Search
Aquestive Therapeutics Inc
AQSTAdd to Watchlist
3.695USD
-0.025-0.67%
Close 07-31 16:00（ET）Quotes delayed by 15 min
463.60MMarket Cap
LossP/E TTM
More Details of Aquestive Therapeutics Inc Company
Aquestive Therapeutics, Inc. is a pharmaceutical company. The Company is engaged in developing orally administered and topical gel products to deliver complex molecules, providing novel alternatives to invasive and inconvenient standard of care therapies. It has four commercialized products marketed by the Company’s licensees in the United States and around the world and is the manufacturer of these licensed products. The Company also collaborates with pharmaceutical companies to bring new molecules to market using proprietary technologies, including PharmFilm, and has proven drug development and commercialization capabilities. The Company is advancing a late-stage proprietary product candidate for the treatment of severe allergic reactions, including anaphylaxis, and an early-stage epinephrine prodrug topical gel product candidate for various possible dermatology conditions. Its portfolio includes Anaphylm, AQST-108, Libervant, Suboxone, and Emylif.
Aquestive Therapeutics Inc Info
Ticker SymbolAQST
Company nameAquestive Therapeutics Inc
IPO dateJul 25, 2018
CEOBarber (Daniel R)
Number of employees142
Security typeOrdinary Share
Fiscal year-endJul 25
Address30 Technology Dr
CityWARREN
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code07059-5166
Phone19089411900
Websitehttps://aquestive.com/
Ticker SymbolAQST
IPO dateJul 25, 2018
CEOBarber (Daniel R)
Company Executives of Aquestive Therapeutics Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Daniel Barber
Mr. Daniel Barber
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.64M
-1.53%
Ms. Lori J. Braender, J.D.
Ms. Lori J. Braender, J.D.
Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
517.40K
-40.94%
Dr. Carl N. Kraus, M.D.
Dr. Carl N. Kraus, M.D.
Chief Medical Officer
Chief Medical Officer
282.48K
-7.18%
Mr. Peter E. Boyd
Mr. Peter E. Boyd
Senior Vice President - Information Technology, Human Resources and Communications
Senior Vice President - Information Technology, Human Resources and Communications
281.51K
-20.17%
Ms. Sherry Korczynski
Ms. Sherry Korczynski
Chief Commercial Officer
Chief Commercial Officer
238.40K
-1.14%
Ms. Cassie Jung
Ms. Cassie Jung
Chief Operating Officer
Chief Operating Officer
200.56K
-36.27%
Dr. Gregory B. Brown, M.D.
Dr. Gregory B. Brown, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
75.08K
--
Mrs. Abigail L. Jenkins
Mrs. Abigail L. Jenkins
Independent Director
Independent Director
19.00K
--
Dr. Melina T. Cioffi, Pharm.D.
Dr. Melina T. Cioffi, Pharm.D.
Senior Vice President - Regulatory Affairs
Senior Vice President - Regulatory Affairs
--
--
Mr. John S. Cochran, CPA
Mr. John S. Cochran, CPA
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Daniel Barber
Mr. Daniel Barber
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.64M
-1.53%
Ms. Lori J. Braender, J.D.
Ms. Lori J. Braender, J.D.
Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
Chief Legal Officer, Chief Compliance Officer and Corporate Secretary
517.40K
-40.94%
Dr. Carl N. Kraus, M.D.
Dr. Carl N. Kraus, M.D.
Chief Medical Officer
Chief Medical Officer
282.48K
-7.18%
Mr. Peter E. Boyd
Mr. Peter E. Boyd
Senior Vice President - Information Technology, Human Resources and Communications
Senior Vice President - Information Technology, Human Resources and Communications
281.51K
-20.17%
Ms. Sherry Korczynski
Ms. Sherry Korczynski
Chief Commercial Officer
Chief Commercial Officer
238.40K
-1.14%
Ms. Cassie Jung
Ms. Cassie Jung
Chief Operating Officer
Chief Operating Officer
200.56K
-36.27%
FAQs
Who are the top five shareholders of Aquestive Therapeutics Inc?
The top five shareholders of Aquestive Therapeutics Inc are: Mr. Daniel Barber
How many institutions hold shares of Aquestive Therapeutics Inc (AQST)?
As of 2026Q1, 350 institutions hold shares of Aquestive Therapeutics Inc, with a combined market value of approximately 74.94M, accounting for 60.30% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -7481130.00.